Cleared Traditional

K223724 - MOZI TPS

K223724 is an FDA 510(k) clearance for MOZI TPS, manufactured by Manteia Technologies Co., Ltd.. The device is a Class 2 Radiology device with product code MUJ cleared through the Traditional 510(k) pathway after a 209-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jul 2023
Decision
209d
Days
Class 2
Risk

K223724 is an FDA 510(k) clearance for the MOZI TPS. Classified as System, Planning, Radiation Therapy Treatment (product code MUJ), Class II - Special Controls.

Submitted by Manteia Technologies Co., Ltd. (Xiamen, CN). The FDA issued a Cleared decision on July 10, 2023 after a review of 209 days - an extended review cycle.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.5050 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Radiology review framework, consistent with the majority of Class II 510(k) submissions.

View all Manteia Technologies Co., Ltd. devices

FDA 510(k) Submission Details - K223724

510(k) Number K223724 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 13, 2022
Decision Date July 10, 2023
Days to Decision 209 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
102d slower than avg
Panel avg: 107d · This submission: 209d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

MUJ Device Classification - Class 2, Special Controls

Product Code MUJ System, Planning, Radiation Therapy Treatment
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.5050
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Peers - MUJ System, Planning, Radiation Therapy Treatment

All 144
Devices cleared under the same product code (MUJ) and FDA review panel - the closest regulatory comparables to K223724.
ART-Plan
K232479 · Therapanacea · Dec 2023
Panther TPS
K231825 · Prowess, Inc. · Dec 2023
VariSeed (v10)
K232400 · Varian Medical Systems · Sep 2023
Eclipse Treatment Planning System (v18.0)
K230557 · Varian Medical Systems, Inc. · May 2023
Radiation Planning Assistant (RPA)
K222728 · University of Texas, MD Anderson Cancer Center · May 2023
RayStation 12A
K222312 · RaySearch Laboratories AB (PUBL) · Mar 2023